Studies indicate that Sirtuin 3 activator theacrine improved heart function after estrogen-deficient mice myocardial infarction by boosting sirtuin 3 levels and modulating the β-catenin/PPARγ signaling pathway. This evidence concerns the gene PPARG and myocardial infarction.